-
In its 2022 ESG Report, Moderna provides an update on how it is advancing its ESG strategy against five guiding focus areas for ongoing and future efforts.
-
At Moderna, our commitment to serve the communities where we live and work has always been part of our identity, and we constantly strive to extend our impact on society.
-
Impacting Human Health: Moderna’s 2021 ESG Report Impacting Human Health 2021 ESG Report" with Moderna logo" typeof="foaf:Image" />Fri, 06/24/2022 - 09:00 Type of Content Article Layout Standard Format Body In its 2021 ESG Report, Moderna outlines its corporate responsibility strategy and defines five guiding focus areas for ongoing and future efforts: Medicines for patients Employees Environment Community Governance and ethics The report also includes updates to the progress Moderna has made
-
Moderna Launches New Charitable Foundation Mon, 04/04/2022 - 10:00 Subheader Initial grants of approximately $5 million awarded to local and global nonprofits that support groups and causes disproportionately affected by COVID-19 Type of Content Press Release Layout Standard Format Body CAMBRIDGE, Mass., April 4, 2022 /3BL Media/ - Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced the launch of the Moderna Charitable
-
European Union and European Economic Area Countries to Donate More than 70 Million Doses of Moderna COVID-19 Vaccine to COVAX in 2021
-
Moderna Announces Pledge to Achieve Net-Zero Carbon Emissions Globally by 2030
-
AIDS Healthcare Foundation (AHF) praised today Merck and Ridgeback Biotherapeutics for granting a royalty-free license to manufacture their COVID-19 antiviral drug molnupiravir in more than 100 developing countries. AHF calls on Moderna, Pfizer, and Johnson & Johnson to follow Merck’s example and voluntarily grant royalty-free manufacturing and distribution rights for their COVID-19 vaccines and facilitate technology transfers to expand generic vaccine production around the world. “If Merck
-
Today the Centers for Disease Control and Prevention (CDC) concurred with previous recommendations made by the Food and Drug Administration (FDA) and the Advisory Committee on Immunization Practices (ACIP), officially recommending “booster” doses of the Pfizer-BioNTech COVID-19 vaccine for certain eligible populations at least 6 months after the second dose of the Pfizer-BioNTech COVID-19 vaccine. As a proud partner in the Federal Retail Pharmacy Program, Rite Aid is prepared to begin administer
-
AHF is encouraged by President Biden’s announcements regarding global vaccination but cautions dramatic, game changing action is required to vaccinate our world
-
Bahar's recent research takes a look at the ESG data on each of the vaccine manufactures: Moderna Inc. Pfizer Inc., and Johnson & Johnson.
-
SOURCE: CSRHub DESCRIPTION:As previously seen on Skytop and published with permission. Many of us have recently pondered the question: which vaccine is better—Pfizer, Moderna, or JJ? Those of us interested in sustainability may also want to know which of these companies has the best ESG (Environment, Social, Governance) performance? CSRHub’s ESG ratings service tracks all three companies (we currently track more than 45,000 entities). All three companies have above average ratings. All Three Comp
-
Initial up-front endowment of $50 million
Foundation to support charitable organizations and causes that promote public health, healthcare and educational opportunities, particularly in underserved populations
-
Working with Skytop Strategies, CSRHub took a look at the ESG data on the three major Covid-19 vaccine manufactures
-
SOURCE: CSRHub DESCRIPTION:Those interested in sustainability should be interested in a different way of comparing the major vaccines. Vaccine-producing companies have made huge contributions to fighting the COVID plague. They have spent millions of dollars developing and manufacturing products that have only moderate financial benefit, but deliver big social value. Working with Skytop Strategies, CSRHub took a look at the ESG data on three major vaccine manufactures. Our article digs below the t
-
Grocer continues disaster relief partnership with American Red Cross with $250,000 donation
-
CR Forum Bestows Additional Honors to Outstanding Clinical Research Organizations for Groundbreaking Clinical and Translational Research Advancements with 2021 Top 10 Clinical Research Achievement Awards
-
\"If ever there was a time to rally around open technology and collaboration, it's now,\" said Jason Kelley, Managing Partner, Global Strategic Alliances Leader for IBM.
-
Long Island Jewish Medical Center nurse Sandra Lindsay’s historic first Pfizer-BioNTech vaccine will now be part of National Museum of American History Collections
-
FedEx Express Canada, a subsidiary of FedEx Corp., and Innomar Strategies, announced recently that the country’s first operations to distribute the Moderna COVID-19 vaccine in Canada on behalf of the Government of Canada are underway.
-
FedEx Express, a subsidiary of FedEx Corp. (NYSE: FDX) and the world’s largest express transportation company, announced recently that operations are in motion to transport Moderna’s COVID-19 vaccines for McKesson Corp. throughout the United States.
-
Amazon.com, Inc. (NASDAQ: AMZN) today announced financial results for its third quarter ended September 30, 2020. Operating cash flow increased 56% to $55.3 billion for the trailing twelve months, compared with $35.3 billion for the trailing twelve months ended September 30, 2019. Free cash flow increased to $29.5 billion for the trailing twelve months, compared with $23.5 billion for the trailing twelve months ended September 30, 2019. Free cash flow less principal repayments of finance leases